Literature DB >> 18059028

Invasive breast cancer cells exhibit increased mobility of the actin-binding protein CapG.

Malte Renz1, Beate Betz, Dieter Niederacher, Hans Georg Bender, Jörg Langowski.   

Abstract

The CapG protein, a Gelsolin-related actin-binding protein, is expressed at higher levels in breast cancer, especially in metastasizing breast cancer, than in normal breast epithelium. Furthermore, it is known that an increased expression of the CapG protein triggers an increase in cell motility. According to in vitro experiments, it was supposed that it is the nuclear fraction of the protein, which causes the increase in cell motility. Here, we examined the dynamical distribution of the CapG protein within the living cell, i.e. the import of the CapG protein into the nucleus. The nuclear import kinetics of invasive, metastasizing breast cancer cells were compared to the import kinetics of non-neoplastic cells similar to normal breast epithelium. FRAP kinetics showed a highly significant increase in the recovery of photobleached CapG-eGFP in the cancer cells, so that a differentiation of invasive, metastasizing cells and non-invasive, non-metastasizing cells on the basis of transport processes of the CapG protein between the nucleus and the cytoplasm seems to be possible. Comprehension of the mobility and compartmentalization of the CapG protein in normal and in cancer cells in vivo could constitute a new basis to characterize the invasiveness and metastasizing potential of breast cancer. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18059028     DOI: 10.1002/ijc.23215

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  Dynamics of the CapG actin-binding protein in the cell nucleus studied by FRAP and FCS.

Authors:  Malte Renz; Jörg Langowski
Journal:  Chromosome Res       Date:  2008       Impact factor: 5.239

2.  BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.

Authors:  David M Gau; Jamie L Lesnock; Brian L Hood; Rohit Bhargava; Mai Sun; Kathleen Darcy; Soumya Luthra; Uma Chandran; Thomas P Conrads; Robert P Edwards; Joseph L Kelley; Thomas C Krivak; Partha Roy
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis.

Authors:  Si-Guang Xu; Pei-Jun Yan; Zhi-Ming Shao
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-14       Impact factor: 4.553

4.  Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan; Vincenzo Costigliola; Daniela Trog; Michael Braun; Manuel Debald; Walther Kuhn; Hans H Schild
Journal:  EPMA J       Date:  2013-02-19       Impact factor: 6.543

5.  Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.

Authors:  O Berthier-Vergnes; M El Kharbili; A de la Fouchardière; T Pointecouteau; P Verrando; A Wierinckx; J Lachuer; F Le Naour; J Lamartine
Journal:  Br J Cancer       Date:  2010-11-16       Impact factor: 7.640

6.  New insight into benign tumours of major salivary glands by proteomic approach.

Authors:  Elena Donadio; Laura Giusti; Veronica Seccia; Federica Ciregia; Ylenia da Valle; Iacopo Dallan; Tiziana Ventroni; Gino Giannaccini; Stefano Sellari-Franceschini; Antonio Lucacchini
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

7.  Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells.

Authors:  Tanya C Burch; Megan T Watson; Julius O Nyalwidhe
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

8.  Macrophage capping protein CapG is a putative oncogene involved in migration and invasiveness in ovarian carcinoma.

Authors:  J Glaser; M H D Neumann; Qi Mei; B Betz; N Seier; I Beyer; T Fehm; H Neubauer; D Niederacher; M C Fleisch
Journal:  Biomed Res Int       Date:  2014-04-02       Impact factor: 3.411

9.  Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation.

Authors:  Hsin-I Ma; Dueng-Yuan Hueng; Hao-Ai Shui; Jun-Ming Han; Chi-Hsien Wang; Ying-Hsiu Lai; Shi-Yuan Cheng; Xiao Xiao; Ming-Teh Chen; Yi-Ping Yang
Journal:  Int J Mol Sci       Date:  2014-03-12       Impact factor: 5.923

10.  Molecular characterization of severin from Clonorchis sinensis excretory/secretory products and its potential anti-apoptotic role in hepatocarcinoma PLC cells.

Authors:  Xueqing Chen; Shan Li; Lei He; Xiaoyun Wang; Pei Liang; Wenjun Chen; Meng Bian; Mengyu Ren; Jinsi Lin; Chi Liang; Jin Xu; Zhongdao Wu; Xuerong Li; Yan Huang; Xinbing Yu
Journal:  PLoS Negl Trop Dis       Date:  2013-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.